These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 28685321)

  • 1. Targeting FGFR in Squamous Cell Carcinoma of the Lung.
    Hashemi-Sadraei N; Hanna N
    Target Oncol; 2017 Dec; 12(6):741-755. PubMed ID: 28685321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Progress on the Study of Targeting FGFR in Squamous Non-small Cell Lung Cancer].
    Dong M; Li T; Chen J
    Zhongguo Fei Ai Za Zhi; 2018 Feb; 21(2):116-120. PubMed ID: 29526179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibroblast Growth Factor Receptor (FGFR): A New Target for Non-small Cell Lung Cancer Therapy.
    Biello F; Burrafato G; Rijavec E; Genova C; Barletta G; Truini A; Coco S; Bello MG; Alama A; Boccardo F; Grossi F
    Anticancer Agents Med Chem; 2016; 16(9):1142-54. PubMed ID: 26845137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of FGF receptors as an emerging therapeutic target in lung squamous cell carcinoma.
    Lim SM; Kim HR; Shim HS; Soo RA; Cho BC
    Future Oncol; 2013 Mar; 9(3):377-86. PubMed ID: 23469973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigational drugs targeting fibroblast growth factor receptor in the treatment of non-small cell lung cancer.
    Rijavec E; Genova C; Barletta G; Biello F; Rossi G; Tagliamento M; Dal Bello MG; Coco S; Vanni I; Boccardo S; Alama A; Grossi F
    Expert Opin Investig Drugs; 2017 May; 26(5):551-561. PubMed ID: 28388262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FGFR Signaling as a Target for Lung Cancer Therapy.
    Desai A; Adjei AA
    J Thorac Oncol; 2016 Jan; 11(1):9-20. PubMed ID: 26762735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibroblast Growth Factor (FGF) Receptor/FGF Inhibitors: Novel Targets and Strategies for Optimization of Response of Solid Tumors.
    Hierro C; Rodon J; Tabernero J
    Semin Oncol; 2015 Dec; 42(6):801-19. PubMed ID: 26615127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibroblast growth factor receptor signaling in hereditary and neoplastic disease: biologic and clinical implications.
    Helsten T; Schwaederle M; Kurzrock R
    Cancer Metastasis Rev; 2015 Sep; 34(3):479-96. PubMed ID: 26224133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent developments and advances of FGFR as a potential target in cancer.
    Xue WJ; Li MT; Chen L; Sun LP; Li YY
    Future Med Chem; 2018 Sep; 10(17):2109-2126. PubMed ID: 30066580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FGFR gene alterations in lung squamous cell carcinoma are potential targets for the multikinase inhibitor nintedanib.
    Hibi M; Kaneda H; Tanizaki J; Sakai K; Togashi Y; Terashima M; De Velasco MA; Fujita Y; Banno E; Nakamura Y; Takeda M; Ito A; Mitsudomi T; Nakagawa K; Okamoto I; Nishio K
    Cancer Sci; 2016 Nov; 107(11):1667-1676. PubMed ID: 27581340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FGFR as potential target in the treatment of squamous non small cell lung cancer.
    Tiseo M; Gelsomino F; Alfieri R; Cavazzoni A; Bozzetti C; De Giorgi AM; Petronini PG; Ardizzoni A
    Cancer Treat Rev; 2015 Jun; 41(6):527-39. PubMed ID: 25959741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibroblast growth factor signaling and inhibition in non-small cell lung cancer and their role in squamous cell tumors.
    Salgia R
    Cancer Med; 2014 Jun; 3(3):681-92. PubMed ID: 24711160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomic aberrations in the FGFR pathway: opportunities for targeted therapies in solid tumors.
    Dienstmann R; Rodon J; Prat A; Perez-Garcia J; Adamo B; Felip E; Cortes J; Iafrate AJ; Nuciforo P; Tabernero J
    Ann Oncol; 2014 Mar; 25(3):552-563. PubMed ID: 24265351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of the FGF/FGFR System Induces Apoptosis in Lung Cancer Cells via c-Myc Downregulation and Oxidative Stress.
    Giacomini A; Taranto S; Rezzola S; Matarazzo S; Grillo E; Bugatti M; Scotuzzi A; Guerra J; Di Trani M; Presta M; Ronca R
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33317057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting FGFR Signaling in Cancer.
    Touat M; Ileana E; Postel-Vinay S; André F; Soria JC
    Clin Cancer Res; 2015 Jun; 21(12):2684-94. PubMed ID: 26078430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibroblast Growth Factor Receptor Signaling in Skin Cancers.
    Czyz M
    Cells; 2019 Jun; 8(6):. PubMed ID: 31167513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting fibroblast growth factor receptor (FGFR) pathway in renal cell carcinoma.
    Massari F; Ciccarese C; Santoni M; Lopez-Beltran A; Scarpelli M; Montironi R; Cheng L
    Expert Rev Anticancer Ther; 2015; 15(12):1367-9. PubMed ID: 26568023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting the fibroblast growth factor receptor family in cancer.
    Hallinan N; Finn S; Cuffe S; Rafee S; O'Byrne K; Gately K
    Cancer Treat Rev; 2016 May; 46():51-62. PubMed ID: 27109926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The potential of fibroblast growth factor/fibroblast growth factor receptor signaling as a therapeutic target in tumor angiogenesis.
    Ronca R; Giacomini A; Rusnati M; Presta M
    Expert Opin Ther Targets; 2015; 19(10):1361-77. PubMed ID: 26125971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting fibroblast growth factor receptor pathway in breast cancer.
    Criscitiello C; Esposito A; De Placido S; Curigliano G
    Curr Opin Oncol; 2015 Nov; 27(6):452-6. PubMed ID: 26397764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.